Cardiovascular Business

Is it TAVR or TAVI? They mean the same thing, but a new editorial in European Heart Journal, a European Society of Cardiology publication, asks the world's medical societies to come together and agree on one acronym instead of using both.

Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

TAVR adoption in Africa has been relatively slow, but cardiologists throughout the continent have made considerable progress. New data does show that there is some work to be done before outcomes will rival what is seen in many other parts of the world.

Patients typically stay in the hospital after receiving the titanium device from BiVACOR In this case, however, the patient was able to wait for a donated heart from the comfort of his own home.

Multiple women have come forward with similar allegations against the Texas cardiologist. Police believe there may be additional victims as well.

Researchers explored data from nearly 80,000 patients, comparing the newest clot-busting stroke drug from Genentech with its predecessor.

CDC data shows that mortality from heart failure-related cardiac arrest has decreased significantly in the last 25 years. However, researchers noted, care teams still have considerable work to do.

The donor-derived cell-free DNA tests from CareDx, Inc. are designed to limit the use of biopsies and other more invasive treatment options. These tests have been available for adult patients for years now.

Incoming Society for Cardiovascular Angiography & Interventions?(SCAI) President Srihari Naidu, MD, FACC, FAHA, FSCAI, professor of medicine, New York Medical College, and director of the cath labs and Hypertrophic Cardiomyopathy (HCM) National Center of Excellence at Westchester Medical Center, spoke with Cardiovascular Business Digital Editor Dave Fornell in a video interview at #CRT2025 about the plans for SCAI in the coming year. Naidu is also a recent author, creating a children's book about HCM with a patient, former Miss Ohio and big HCM patient advocate Lindsay Davis. - https://lnkd.in/gU8-TUi4